{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:04:50Z","timestamp":1792605890174,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.phrs.2022.106640","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T11:32:32Z","timestamp":1673091152000},"page":"106640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Blocking the HGF-MET pathway induces resolution of neutrophilic inflammation by promoting neutrophil apoptosis and efferocytosis"],"prefix":"10.1016","volume":"188","author":[{"given":"Franciel Batista","family":"Felix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Priscila","family":"Vago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora Gonzaga","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcius Amorim","family":"Beltrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora de Oliveira","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Clara Paiva","family":"Menezes dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso Martins","family":"Queiroz-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirl\u00e2ndia Pires","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio Almeida","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico Marianetti","family":"Soriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro Martins","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Pinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2022.106640_bib1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2010.03.006","article-title":"Inflammation 2010: new adventures of an old flame","volume":"140","author":"Medzhitov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2022.106640_bib2","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1126\/science.abi5200","article-title":"The spectrum of inflammatory responses","volume":"374","author":"Medzhitov","year":"2021","journal-title":"Sci. (80-. )"},{"key":"10.1016\/j.phrs.2022.106640_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev-immunol-061020-053734","article-title":"Tissue homeostasis and inflammation","volume":"39","author":"Meizlish","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.phrs.2022.106640_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri3399","article-title":"Neutrophil recruitment and function in health and inflammation","volume":"13","author":"Kolaczkowska","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2022.106640_bib5","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ni.2921","article-title":"Neutrophils at work","volume":"15","author":"Nauseef","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2022.106640_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/cells2020330","article-title":"Targeting neutrophil apoptosis for enhancing the resolution of inflammation","volume":"2","author":"El Kebir","year":"2013","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2022.106640_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101506","article-title":"Dimensions of neutrophil life and fate","author":"Hidalgo","year":"2021","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.phrs.2022.106640_bib8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.immuni.2022.03.016","article-title":"Nonresolving inflammation redux","volume":"55","author":"Nathan","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2022.106640_bib9","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2022.106640_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2021.729134","article-title":"Harnessing inflammation resolution in arthritis: current understanding of specialized pro-resolving lipid mediators\u2019 contribution to arthritis physiopathology and future perspectives","volume":"12","author":"Zaninelli","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2022.106640_bib11","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"B\u00e4ck","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.phrs.2022.106640_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2022.106640_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/bph.15619","article-title":"Asthma: role of the angiotensin-(1-7)\/Mas (MAS1) pathway in pathophysiology and therapy","author":"Greg\u00f3rio","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2022.106640_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107879","article-title":"Resolution of inflammation: an organizing principle in biology and medicine","volume":"227","author":"Panigrahy","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2022.106640_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107670","article-title":"Carcinogenesis: failure of resolution of inflammation","volume":"218","author":"Fishbein","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2022.106640_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nri3607","article-title":"Apoptotic cell clearance: basic biology and therapeutic potential","volume":"14","author":"Poon","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2022.106640_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/imr.12453","article-title":"Clearance of apoptotic neutrophils and resolution of inflammation","volume":"273","author":"Greenlee-Wacker","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.phrs.2022.106640_bib18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2022.106640_bib19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.it.2019.01.007","article-title":"Mediators of the Resolution of the Inflammatory Response","volume":"40","author":"Sugimoto","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.phrs.2022.106640_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/imm.13371","article-title":"CD300a contributes to the resolution of articular inflammation triggered by MSU crystals by controlling neutrophil apoptosis","volume":"164","author":"Valiate","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.phrs.2022.106640_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105445","article-title":"Therapeutic potential of the FPR2\/ALX agonist AT-01-KG in the resolution of articular inflammation","volume":"165","author":"Galv\u00e3o","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2022.106640_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.00058","article-title":"Angiotensin-(1-7) promotes resolution of eosinophilic inflammation in an experimental model of asthma","volume":"9","author":"Magalhaes","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2022.106640_bib23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.cmet.2020.01.001","article-title":"Macrophage metabolism of apoptotic cell-derived arginine promotes continual efferocytosis and resolution of injury","volume":"31","author":"Yurdagul","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2022.106640_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2021.773344","article-title":"Efferocytosis in the central nervous system","volume":"9","author":"Zhao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.phrs.2022.106640_bib25","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1038\/onc.2016.36","article-title":"Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma","volume":"35","author":"Finisguerra","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2022.106640_bib26","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nrclinonc.2017.40","article-title":"Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges","volume":"14","author":"Bradley","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phrs.2022.106640_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biopha.2017.01.045","article-title":"A mini-review of c-Met as a potential therapeutic target in melanoma","volume":"88","author":"Al-U\u2019datt","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2022.106640_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24367-3","article-title":"Structural basis of the activation of c-MET receptor","volume":"12","author":"Uchikawa","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2022.106640_bib29","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1038\/s41388-020-1193-8","article-title":"MET targeting: time for a rematch","volume":"39","author":"Koch","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2022.106640_bib30","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1038\/s41388-021-01863-w","article-title":"HGF\/c-MET pathway in cancer: from molecular characterization to clinical evidence","volume":"40","author":"Fu","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2022.106640_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41568-018-0002-y","article-title":"Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy","volume":"18","author":"Comoglio","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2022.106640_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms8174","article-title":"Activating MET kinase rearrangements in melanoma and Spitz tumours","volume":"6","author":"Yeh","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2022.106640_bib33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41571-020-0377-z","article-title":"MET-dependent solid tumours \u2014 molecular diagnosis and targeted therapy","volume":"17","author":"Guo","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phrs.2022.106640_bib34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/rheumatology\/keaa310","article-title":"Inhibition of hepatocyte growth factor\/c-Met signalling abrogates joint destruction by suppressing monocyte migration in rheumatoid arthritis","volume":"60","author":"Hosonuma","year":"2021","journal-title":"Rheumatol. (U. Kingd. )"},{"key":"10.1016\/j.phrs.2022.106640_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bone.2015.02.001","article-title":"Elevated hepatocyte growth factor levels in osteoarthritis osteoblasts contribute to their altered response to bone morphogenetic protein-2 and reduced mineralization capacity","volume":"75","author":"Abed","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.phrs.2022.106640_bib36","first-page":"1","article-title":"CD4+c-Met+Itg\u03b14+ T cell subset promotes murine neuroinflammation","author":"Benkhoucha","year":"2022","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.phrs.2022.106640_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.681516","article-title":"Cytokine signature associated with disease severity in COVID-19","volume":"12","author":"Guo","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2022.106640_bib38","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/ecco-jcc\/jjaa121","article-title":"Neutrophilic HGF-MET signalling exacerbates intestinal inflammation","volume":"14","author":"Stakenborg","year":"2020","journal-title":"J. Crohns. Colitis"},{"key":"10.1016\/j.phrs.2022.106640_bib39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cyto.2015.12.013","article-title":"The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: diverse roles in modulating immune cell functions","volume":"82","author":"Ilangumaran","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.phrs.2022.106640_bib40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.autrev.2014.11.013","article-title":"Hepatocyte growth factor: a regulator of inflammation and autoimmunity","volume":"14","author":"Molnarfi","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.phrs.2022.106640_bib41","first-page":"4","article-title":"c-Met enforces proin fl ammatory and migratory features of human activated CD4 + T cells","author":"Benkhoucha","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.phrs.2022.106640_bib42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nature14407","article-title":"Europe PMC funders group Europe PMC funders author manuscripts MET is required for the recruitment of anti-tumoural neutrophils","volume":"522","author":"Finisguerra","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2022.106640_bib43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/ejso.2001.1133","article-title":"Activated human neutrophils release hepatocyte growth factor\/scatter factor","volume":"27","author":"McCourt","year":"2001","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.phrs.2022.106640_bib44","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1182\/blood.V99.8.2997","article-title":"Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils","volume":"99","author":"Grenier","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2022.106640_bib45","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.immuni.2017.09.012","article-title":"Reactive neutrophil responses dependent on the receptor tyrosine kinase c-MET limit cancer immunotherapy","volume":"47","author":"Glodde","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2022.106640_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2174\/1871520611009010007","article-title":"Discovery of small molecule c-met inhibitors: evolution and profiles of clinical candidates","volume":"10","author":"Underiner","year":"2012","journal-title":"Anticancer. Agents Med. Chem."},{"key":"10.1016\/j.phrs.2022.106640_bib47","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/13543776.2022.2008356","article-title":"An updated patent review of small-molecule c-Met kinase inhibitors (2018-present","volume":"32","author":"Chu","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.phrs.2022.106640_bib48","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.1021\/jm300967g","article-title":"Discovery of a novel class of exquisitely selective mesenchymal-epithelial transition factor (c-MET) protein kinase inhibitors and identification of the clinical candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1H -[1,2,3]triazolo[4,5- b]pyrazin-6-yl)-1H -pyraz","volume":"55","author":"Cui","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2022.106640_bib49","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1158\/1535-7163.MCT-11-0839","article-title":"Sensitivity of selected human tumor models to PF-04217903, a novel selective c-Met kinase inhibitor","volume":"11","author":"Zou","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phrs.2022.106640_bib50","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/2159-8290.CD-11-0240","article-title":"Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors","volume":"2","author":"Sennino","year":"2012","journal-title":"Cancer Disco"},{"key":"10.1016\/j.phrs.2022.106640_bib51","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1021\/acs.nanolett.8b01879","article-title":"Peptide-functionalized nanoinhibitor restrains brain tumor growth by abrogating mesenchymal-epithelial Transition Factor (MET) signaling","volume":"18","author":"Wu","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.phrs.2022.106640_bib52","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.7150\/thno.54741","article-title":"Kinomic profile in patient-derived glioma cells during hypoxia reveals c-MET-PI3K dependency for adaptation","volume":"11","author":"Cheng","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2022.106640_bib53","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1200\/JCO.2012.46.4289","article-title":"Initial clinical sensitivity and acquired resistance to MET inhibition in MET-mutated papillary renal cell carcinoma","volume":"31","author":"Diamond","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2022.106640_bib54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1189\/jlb.0112008","article-title":"Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis","volume":"92","author":"Vago","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.phrs.2022.106640_bib55","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/art.33355","article-title":"NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B4 in a murine model of gout","volume":"64","author":"Amaral","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.phrs.2022.106640_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2021.662308","article-title":"Biochanin A regulates key steps of inflammation resolution in a model of antigen-induced arthritis via GPR30\/PKA-dependent mechanism","volume":"12","author":"Felix","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2022.106640_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.01505","article-title":"The inhibition of phosphoinositide-3 kinases induce resolution of inflammation in a gout model","volume":"9","author":"Galv\u00e3o","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2022.106640_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.03120","article-title":"Sensory ganglia-specific TNF expression is associated with persistent nociception after resolution of inflammation","volume":"10","author":"Gon\u00e7alves","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2022.106640_bib59","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.4049\/jimmunol.1101195","article-title":"Experimental arthritis triggers periodontal disease in mice: involvement of TNF-\u03b1 and the oral microbiota","volume":"187","author":"Queiroz-Junior","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2022.106640_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells8090964","article-title":"ROCK inhibition drives resolution of acute inflammation by enhancing neutrophil apoptosis","volume":"8","author":"Galv\u00e3o","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2022.106640_bib61","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/eji.201848049","article-title":"Inhibition of the sphingosine-1-phosphate pathway promotes the resolution of neutrophilic inflammation","volume":"49","author":"Perez","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.phrs.2022.106640_bib62","first-page":"1","article-title":"Experimental analysis of apoptotic thymocyte engulfment by macrophages","author":"Zhen","year":"2019","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.phrs.2022.106640_bib63","doi-asserted-by":"crossref","unstructured":"I. Zaidan, I. Galv\u00e3o, L.P. Sousa, Angiotensin- ( 1\u20137)\/ MasR axis promotes migration of monocytes \/ macrophages with a regulatory phenotype to perform phagocytosis and efferocytosis, (2021).","DOI":"10.1172\/jci.insight.147819"},{"key":"10.1016\/j.phrs.2022.106640_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010128","article-title":"Cyclic AMP regulates key features of macrophages","author":"Negreiros-Lima","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2022.106640_bib65","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bph.14153","article-title":"Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers","volume":"175","author":"Curtis","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2022.106640_bib66","doi-asserted-by":"crossref","first-page":"13758","DOI":"10.1074\/jbc.M117.800391","article-title":"The resolution of acute inflammation induced by cyclic AMP is dependent on Annexin A1","volume":"292","author":"Lima","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2022.106640_bib67","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1476-5381.2010.00895.x","article-title":"Cooperative role of tumour necrosis factor-\u03b1, interleukin-1\u03b2 and neutrophils in a novel behavioural model that concomitantly demonstrates articular inflammation and hypernociception in mice","volume":"162","author":"Sachs","year":"2011","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2022.106640_bib68","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8239258","article-title":"Annexin A1 and the resolution of inflammation: modulation of neutrophil recruitment, apoptosis, and clearance","volume":"2016","author":"Sugimoto","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.phrs.2022.106640_bib69","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri2470","article-title":"Annexin A1 and glucocorticoids as effectors of the resolution of inflammation","volume":"9","author":"Perretti","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2022.106640_bib70","first-page":"1405","article-title":"Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: Role in tumor progression and death","volume":"63","author":"Wislez","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.phrs.2022.106640_bib71","first-page":"1772","article-title":"Hepatocyte Growth Factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis","volume":"28","author":"Nagashima","year":"2001","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.phrs.2022.106640_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2193-1801-3-554","article-title":"Differential regulation of c-Met signaling pathways for synovial cell function","volume":"3","author":"Shibasaki","year":"2014","journal-title":"Springerplus"},{"key":"10.1016\/j.phrs.2022.106640_bib73","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/art.30163","article-title":"Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis","volume":"63","author":"Grandaunet","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.phrs.2022.106640_bib74","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1186\/ar4252","article-title":"Molecular targeting of hepatocyte growth factor by an antagonist, NK4, in the treatment of rheumatoid arthritis","volume":"15","author":"Tsunemi","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.phrs.2022.106640_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.866747","article-title":"Targeting neutrophils for promoting the resolution of inflammation","volume":"13","author":"Filep","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2022.106640_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105998","article-title":"The natural product berberine synergizes with osimertinib preferentially against MET-amplified osimertinib-resistant lung cancer via direct MET inhibition","volume":"175","author":"Chen","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2022.106640_bib77","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1073\/pnas.98.1.247","article-title":"Anti-apoptotic signaling by hepatocyte growth factor\/Met via the phosphatidylinositol 3-kinase\/Akt and mitogen-activated protein kinase pathways","volume":"98","author":"Xiao","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2022.106640_bib78","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/path.4133","article-title":"Macrophage plasticity and polarization in tissue repair and remodelling","volume":"229","author":"Mantovani","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.phrs.2022.106640_bib79","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/glia.20945","article-title":"Expression of the HGF receptor c-met by macrophages in experimental autoimmune encephalomyelitis","volume":"58","author":"Moransard","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2022.106640_bib80","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1158\/1541-7786.MCR-21-0009","article-title":"Inflammation-induced metastatic colonization of the lung is facilitated by hepatocyte growth factor-secreting monocyte-derived macrophages","volume":"19","author":"Arif","year":"2021","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.phrs.2022.106640_bib81","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1096\/fba.2019-00074","article-title":"Hepatocyte growth factor is upregulated in ischemic retina and contributes to retinal vascular leakage and neovascularization","volume":"2","author":"Lorenc","year":"2020","journal-title":"FASEB BioAdvances"},{"key":"10.1016\/j.phrs.2022.106640_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.02135","article-title":"HGF-MET signaling shifts M1 macrophages toward an M2-like phenotype through PI3K-mediated induction of arginase-1 expression","volume":"11","author":"Nishikoba","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2022.106640_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00914","article-title":"Hepatocyte growth factor regulates macrophage transition to the M2 phenotype and promotes murine skeletal muscle regeneration","volume":"10","author":"Choi","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2022.106640_bib84","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.immuni.2019.04.018","article-title":"Living on the Edge: Efferocytosis at the Interface of Homeostasis and Pathology","volume":"50","author":"Morioka","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2022.106640_bib85","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrrheum.2014.64","article-title":"Mechanisms, impact and management of pain in rheumatoid arthritis","volume":"10","author":"Walsh","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2022.106640_bib86","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/eji.201646551","article-title":"Annexin A1 promotes timely resolution of inflammation in murine gout","volume":"47","author":"Galv\u00e3o","year":"2017","journal-title":"Eur. J. Immunol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822005862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822005862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:38:12Z","timestamp":1760913492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822005862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":86,"alternative-id":["S1043661822005862"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106640","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blocking the HGF-MET pathway induces resolution of neutrophilic inflammation by promoting neutrophil apoptosis and efferocytosis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106640"}}